Aker Biomarine AS Capital Reinvestment Ratio
Aker Biomarine AS capital reinvestment ratio. Aker Biomarine AS (AKBM) has a Capital Reinvestment Ratio of 1.70x as of December 2024, meaning it reinvests 2% of its operating cash flow (Nkr7.60 Million) in capital expenditures (Nkr12.90 Million). See Aker Biomarine AS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aker Biomarine AS (2016–2024)
Capital reinvestment ratio of Aker Biomarine AS from 2016 to 2024. This chart tracks Aker Biomarine AS's Capital Reinvestment Ratio across 8 annual periods. See financial flexibility index of Aker Biomarine AS to measure the company's free cash flow as a share of total liabilities.
Aker Biomarine AS Capital Reinvestment Ratio by Year (2016–2024)
Aker Biomarine AS capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see AKBM cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.89x | Nkr12.20 Million | Nkr23.10 Million | ▲ +82.0% |
| 2023 | 1.04x | Nkr47.40 Million | Nkr49.30 Million | ▼ -65.9% |
| 2022 | 3.05x | Nkr15.10 Million | Nkr46.10 Million | ▼ -97.3% |
| 2021 | 111.26x | Nkr729.00K | Nkr81.11 Million | ▲ +978.9% |
| 2019 | 10.31x | Nkr12.31 Million | Nkr126.92 Million | ▲ +26.2% |
| 2018 | 8.17x | Nkr7.89 Million | Nkr64.51 Million | ▼ -32.6% |
| 2017 | 12.12x | Nkr9.17 Million | Nkr111.20 Million | ▲ +2222.5% |
| 2016 | 0.52x | Nkr20.88 Million | Nkr10.90 Million | — |